Number of Shares
1.47 Mil
Current Holdings Value*
$22.92 Mil
% of Portfolio
1.05%
Total Estimate Gain
$1.35 Mil
% of Total Estimate Gain
6.53%

Paradigm Biocapital Advisors LP's Arcutis Biotherapeutics Inc Holding Summary

As of 2025-03-31, Paradigm Biocapital Advisors LP held 1.47 Mil shares of Arcutis Biotherapeutics Inc(ARQT), totaling $22.92 Mil. This investment constitutes 1.05% of their stock portfolio, and Paradigm Biocapital Advisors LP now holds 1.23% of the outstanding Arcutis Biotherapeutics Inc(ARQT) stock.

The initial trade took place in 2025Q1. And since then Paradigm Biocapital Advisors LP has made 1 purchases of ARQT, at an average price of $14.09, for a total of 1.47 Mil shares. Based on historical transaction data and ARQT's current price of $15.01, Paradigm Biocapital Advisors LP's estimated gain on his ARQT holdings is $1.35 Mil, reflecting a 6.53% gain to date.

Paradigm Biocapital Advisors LP ARQT ($15.01) Holding Chart

Paradigm Biocapital Advisors LP ARQT ($15.01) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1